Foreign Travel Advice - UK

Innovation in regulation is shortening timelines for lowest risk clinical trials

Following MHRA approval of a clinical trial, a study on Nuwiq, a recombinant FVIII therapy for the treatment of haemophilia A, can proceed.

Read the original advice at Foreign Travel Advice (UK)

Related Articles

Back to top button